The second mRNA #Covid19 Vaccine developed by German biopharmaceutical company CureVac and its British partner GlaxoSmithKline (GSK) has demonstrated improved immune response and protection than its first vaccine, according to a new study. pic.twitter.com/y2Zs2v7wN7— IANS Tweets (@ians_india) August 17, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


